N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-(2-furyl)-D-alanine>98.0%(HPLC)(T)1g

2,5-Dimethylbenzenesulfonic acid hydrate, 95.0%, 25g

5-(1-Hydroxyethyl)-2-methylpyridine, 95.0%, 1g

Methyl 4-(bromomethyl)-3-fluorobenzoate, 95.0%, 5g

Methyl 4-fluorobicyclo[2.2.2]octane-1-carboxylate, 98%, 500mg

1-{4-[(1-hydroxycyclobutyl)methyl]piperazin-1-yl}ethan-1-one, 95.0%, 250mg

Piperazine-1,4-bis(2-ethanesulfonic Acid) Monosodium Salt [Good's buffer component for biological research]>99.0%(T)25g

2,7,12,17-tetrakis(3,5-dimethoxyphenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1�,?.1?,��.1��,�?]tetracosa-1,3,5,7,9,11,13(22),14,16,18(21),19-undecaene, 95%, 100mg

2,3-Dihydro-1H-pyrrolo[2,3-c]pyridine hydrochloride, 95.0%, 250mg

3-Methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid, 98%, 1g

(1-Methyl-piperidin-4-yl)acetic acid ethyl ester, 95.0%, 1g

METHYL 6-CHLORO-4-METHYLPYRIDAZINE-3-CARBOXYLATE, 95%, 5g

Trial kit Spectra/Por® Biotech CE, 100000 dalton(s), 1 Piece(s)